Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. ESMO
  2. Meeting Calendar
  3. Past Meetings
  4. ESMO Breast Cancer 2024
  5. Satellite Symposia Webcasts

Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>&minus;</b> advanced breast cancer

Co-Chairman opening: Overview of the ESMO BC living guidelines in ER+/HER2- metastatic breast cancer setting

Date

15 May 2024

Session

Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>&minus;</b> advanced breast cancer

Topics

Tumour Site

Breast Cancer

Presenters

Alessandra Gennari

Authors

A. Gennari1, V. Mueller2

Author affiliations

  • 1 Università Degli Studi Del Piemonte Orientale Amedeo Avogadro - Scuola di Medicina, Novara/IT
  • 2 UKE Universitätsklinikum Hamburg-Eppendorf KMTZ, Hamburg/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Clinical experience and takeaways

Presenter: Alessandra Gennari

Session: Menarini Stemline - Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2<b>&minus;</b> advanced breast cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.